P. Khandelwal

Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.

F. Holmes, J. O’Shaughnessy, J. Pippen, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Panitumumab (pmab) regimen evaluation in colorectal cancer to estimate primary response to treatment (PRECEPT): Effect of KRAS mutation status on second-line treatment (tx) with pmab and FOLFIRI

David A. Smith, R. Sikorski, M. Yassine, 2008 .

Phase II trial of weekly docetaxel/ gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer.

J. O’Shaughnessy, L. Asmar, D. Ilegbodu, 2006, Clinical breast cancer.

α-Difluoromethylornithine as Treatment for Metastatic Breast Cancer Patients

J. O’Shaughnessy, Stephen E. Jones, L. Demers, 1999 .

Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.

J. O’Shaughnessy, S. Jones, L. Demers, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancer.

David A. Smith, M. Yassine, A. Cohn, 2011, Clinical colorectal cancer.

A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer.

J. Nemunaitis, D. Garfield, L. Asmar, 2003, Lung cancer.

Results from panitumumab (pmab) regimen evaluation in colorectal cancer to estimate primary response to treatment (PRECEPT): Second-line treatment with pmab and FOLFIRI by tumor KRAS status.

M. Yassine, A. Cohn, M. Neubauer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin, and cyclophosphamide in stage II and III breast cancer.

N. Dimitrov, D. Regan, S. Jones, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.